个性化遗传咨询(POETIC)试验:患者筛查工具改善癌症遗传咨询后患者赋权的混合II型有效性-实施随机临床试验方案
POETIC试验为混合II型有效性-实施随机对照试验,在澳大利亚维多利亚州两家大都市医院联合临床遗传学服务中,评估遗传特异性筛查工具GPRI能否改善癌症遗传咨询后的患者赋权(主要结局),同时从临床医生和医疗服务角度评估实施情况。干预组在就诊前完成GPRI,筛查结果供临床医生就诊时使用;将利用就诊录音、临床医生报告信息、患者报告结局量表和临床数据评估有效性,利用就诊录音、健康经济信息和结构化访谈评估实施。
要点
- POETIC试验评估GPRI筛查工具在癌症遗传咨询中改善患者赋权的有效性及实施情况。
- 干预组在就诊前完成GPRI,筛查结果供临床医生就诊时使用;对照组接受常规护理。
- 试验在澳大利亚维多利亚州两家大都市医院的联合临床遗传学服务中开展。
核心结论
- 试验旨在评估使用GPRI在遗传咨询和遗传性癌症易感基因检测后改善患者结局的有效性和实施情况。
研究设计与样本
- 混合II型有效性-实施随机对照试验,在澳大利亚维多利亚州两家大都市医院的联合临床遗传学服务中开展。
- 符合纳入标准并同意参加POETIC的癌症风险评估转诊患者将随机分配至常规护理组或干预组。
- 干预组在就诊前完成GPRI,筛查结果供临床医生就诊时使用。
- 利用就诊录音、临床医生报告的预约信息、患者报告结局量表和临床数据评估有效性;利用就诊录音、健康经济信息和结构化访谈评估实施情况。
主要发现
- 主要结局为患者赋权;同时从临床医生和医疗服务角度评估GPRI的实施情况。
临床怎么用
- POETIC试验在由遗传学和肿瘤学临床医生多学科团队组成的癌症特异性临床遗传学服务常规临床实践中部署GPRI作为干预措施。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genetic counselling aims to identify, and address, patient needs while facilitating informed decision-making about genetic testing and promoting empowerment and adaptation to genetic information. Increasing demand for cancer genetic testing and genetic counsellor workforce capacity limitations may impact the quality of genetic counselling provided. The use of a validated genetic-specific screening tool, the Genetic Psychosocial Risk Instrument (GPRI), may facilitate patient-centred genetic counselling. The aim of this study is to assess the effectiveness and implementation of using the GPRI in improving patient outcomes after genetic counselling and testing for an inherited cancer predisposition. METHODS: The PersOnalising gEneTIc Counselling (POETIC) trial is a hybrid type 2 effectiveness-implementation trial using a randomised control trial to assess the effectiveness of the GPRI in improving patient empowerment (primary outcome), while also assessing implementation from the perspective of clinicians and the healthcare service. Patients referred for a cancer risk assessment to the conjoint clinical genetics service of two metropolitan hospitals in Victoria, Australia, who meet the eligibility criteria and consent to POETIC will be randomised to the usual care or intervention group. Those in the intervention group will complete the GPRI prior to their appointment with the screening results available for the clinicians' use during the appointment. Appointment audio recordings, clinician-reported information about the appointment, patient-reported outcome measures, and clinical data will be used to examine the effectiveness of using the GPRI. Appointment audio recordings, health economic information, and structured interviews will be used to examine the implementation of the GPRI. DISCUSSION: The POETIC trial takes a pragmatic approach by deploying the GPRI as an intervention in the routine clinical practice of a cancer-specific clinical genetics service that is staffed by a multidisciplinary team of genetics and oncology clinicians. Therefore, the effectiveness and implementation evidence generated from this real-world health service setting aims to optimise the relevance of the outcomes of this trial to the practice of genetic counselling while enhancing the operationalisation of the screening tool in routine practice. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry registration number 12621001582842p. Date of registration: 19th November 2021.
引用
- Forrest LE, Tutty E, De Silva AP, et al. Personalising genetic counselling (POETIC) trial: Protocol for a hybrid type II effectiveness-implementation randomised clinical trial of a patient screening tool to improve patient empowerment after cancer genetic counselling. Trials. 2023. PMID: 37941026. doi:10.1186/s13063-023-07723-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。